Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2021-05-01 (5 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BONDY (93140), Seine-Saint-Denis
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE LE BRIS DU REST : revenue, balance sheet and financial ratios
PHARMACIE LE BRIS DU REST is a French company
founded 5 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BONDY (93140),
this company of category PME
shows in 2025 a net income negative of -78 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LE BRIS DU REST (SIREN 898755509)
Indicator
2025
2024
2023
2022
Revenue
N/C
N/C
N/C
N/C
Net income
-78 366 €
7 655 €
-34 910 €
33 210 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE LE BRIS DU REST records a net loss of 78 k€. This deficit will reduce equity on the balance sheet.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-78 366 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at -1462%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -6%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
-1462.349%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
-5.82%
Solvency indicators evolution PHARMACIE LE BRIS DU REST
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2022
2023
2024
2025
Debt ratio
1882.376
-90690.143
15674.547
-1462.349
Financial autonomy
3.923
-0.079
0.53
-5.82
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
-1462.352025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Excellent
In 2025, the debt ratio of PHARMACIE LE BRIS DU REST (-1462.35) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
-5.82%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch
In 2025, the financial autonomy of PHARMACIE LE BRIS DU REST (-5.8%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Positioning of PHARMACIE LE BRIS DU REST in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LE BRIS DU REST with other companies in the same sector:
Frequently asked questions about PHARMACIE LE BRIS DU REST
What is the revenue of PHARMACIE LE BRIS DU REST ?
The revenue of PHARMACIE LE BRIS DU REST is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE LE BRIS DU REST profitable?
PHARMACIE LE BRIS DU REST recorded a net loss in 2025.
Where is the headquarters of PHARMACIE LE BRIS DU REST ?
The headquarters of PHARMACIE LE BRIS DU REST is located in BONDY (93140), in the department Seine-Saint-Denis.
Where to find the tax return of PHARMACIE LE BRIS DU REST ?
The tax return of PHARMACIE LE BRIS DU REST is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LE BRIS DU REST operate?
PHARMACIE LE BRIS DU REST operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart